QIAGEN Biological Engineering (Shenzhen) Co., Ltd.

QIAGEN is a multinational enterprise specializing in solutions for biomolecular sample preparation, headquartered in Germany. Founded in Germany in 1984, QIAGEN was listed on NASDAQ in New York in 1996. QIAGEN has four regional headquarters globally—Asia Pacific, Japan, North America, and Europe—with 19 subsidiaries, nearly 3,000 employees, over 500 products, more than 400,000 users, 409 approved patents, and over 300 patents pending. It is an industry giant in life science research, applied testing, and clinical diagnostics. As a leader in molecular testing technology and a major global supplier of biomolecular sample preparation solutions, QIAGEN—QIAGEN Biological Technology—is a highly renowned name that many have heard of. Many biological scientists highly praise QIAGEN, commending its biomolecular separation, purification, and preparation technology, and unanimously stating that their scientific research achievements have benefited from QIAGEN's products and technology.